Corresponding Author: Carol M. Mangione, MD, MSPH, David Geffen School of Medicine, University of California, Los Angeles, 10940 Wilshire Blvd, Ste 700, Los Angeles, CA 90024 (firstname.lastname@example.org).
Accepted for Publication: August 17, 2022.
The US Preventive Services Task Force (USPSTF) members: Carol M. Mangione, MD, MSPH; Michael J. Barry, MD; Wanda K. Nicholson, MD, MPH, MBA; Michael Cabana, MD, MA, MPH; David Chelmow, MD; Tumaini Rucker Coker, MD, MBA; Esa M. Davis, MD, MPH; Katrina E. Donahue, MD, MPH; Carlos Roberto Jaén, MD, PhD, MS; Martha Kubik, PhD, RN; Li Li, MD, PhD, MPH; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; John M. Ruiz, PhD; James Stevermer, MD, MSPH; John B. Wong, MD.
Affiliations of The US Preventive Services Task Force (USPSTF) members: University of California, Los Angeles (Mangione); Harvard Medical School, Boston, Massachusetts (Barry); University of North Carolina at Chapel Hill (Nicholson, Donahue); Albert Einstein College of Medicine, New York, New York (Cabana); Virginia Commonwealth University, Richmond (Chelmow); University of Washington, Seattle (Coker); University of Pittsburgh, Pittsburgh, Pennsylvania (Davis); The University of Texas Health Science Center, San Antonio (Jaén); George Mason University, Fairfax, Virginia (Kubik); University of Virginia, Charlottesville (Li); New York University, New York, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); University of Arizona, Tucson (Ruiz); University of Missouri, Columbia (Stevermer); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Mangione had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Brandy Peaker, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms. Published by JAMA®—Journal of the American Medical Association under arrangement with the Agency for Healthcare Research and Quality (AHRQ). ©2022 AMA and United States Government, as represented by the Secretary of the Department of Health and Human Services (HHS), by assignment from the members of the United States Preventive Services Task Force (USPSTF). All rights reserved.
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2019. US Dept of Health and Human Services; 2021.
MH , Bean
SI , Lin
JS . Screening for Syphilis Infection in Nonpregnant Adults and Adolescents: A Targeted Evidence Update for the US Preventive Services Task Force. Evidence Synthesis No. 218. Agency for Healthcare Research and Quality; 2022. AHRQ publication 22-05290-EF-1.
ML , Bean
SI , Lin
JS . Screening for syphilis infection in nonpregnant adults and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA
. Published September 27, 2022. doi:10.1001/jama.2022.8612Google Scholar
SJ , Krist
AH , Owens
et al; US Preventive Services Task Force. Screening for syphilis infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement. JAMA
. 2018;320(9):911-917. doi:10.1001/jama.2018.11785PubMedGoogle ScholarCrossref
K , Grossman
DC , Curry
et al; US Preventive Services Task Force (USPSTF). Screening for syphilis infection in nonpregnant adults and adolescents: US Preventive Services Task Force recommendation statement. JAMA
. 2016;315(21):2321-2327. doi:10.1001/jama.2016.5824PubMedGoogle ScholarCrossref
SE , Grey
JA , Torrone
EA , Weinstock
HS . Increased methamphetamine, injection drug, and heroin use among women and heterosexual men with primary and secondary syphilis—United States, 2013–2017. MMWR Morb Mortal Wkly Rep
. 2019;68(6):144-148. doi:10.15585/mmwr.mm6806a4PubMedGoogle ScholarCrossref
Centers for Disease Control and Prevention. Sexually transmitted diseases (STDs). Reviewed June 29, 2022. Accessed August 15, 2022. https://www.cdc.gov/std
DD , Genzen
JR , Bashleben
CP , Faix
JD , Ansari
MQ . Prevalence of traditional and reverse-algorithm syphilis screening in laboratory practice: a survey of participants in the College of American Pathologists syphilis serology proficiency testing program. Arch Pathol Lab Med
. 2017;141(1):93-97. doi:10.5858/2016-0110-CPPubMedGoogle ScholarCrossref
CC , Klausner
JD , Tran
A . Clinical test performance of a rapid point-of-care syphilis treponemal antibody test: a systematic review and meta-analysis. Clin Infect Dis
. 2020;71(suppl 1):S52-S57. doi:10.1093/cid/ciaa350PubMedGoogle ScholarCrossref
LT , Konda
KA , Vargas
et al. The development of an online risk calculator for the prediction of future syphilis among a high-risk cohort of men who have sex with men and transgender women in Lima, Peru. Sex Health
. 2018;15(3):261-268. doi:10.1071/SH17118PubMedGoogle ScholarCrossref
EPF , Callander
D , Fairley
et al; ACCESS Collaboration. Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis. Clin Infect Dis
. 2017;65(3):389-395. doi:10.1093/cid/cix326PubMedGoogle ScholarCrossref
GL , Fisher
DG , Brocato
J , van Otterloo
L , Khahlil
K , Huckabay
L . Stressful point-of-care rapid testing for human immunodeficiency virus, hepatitis C virus, and syphilis. Int J STD AIDS
. 2017;28(10):975-984. doi:10.1177/0956462416684460PubMedGoogle ScholarCrossref
JA , Gallant
JE , Ghanem
KG , Emmanuel
P , Zingman
BS , Horberg
MA ; Infectious Diseases Society of America. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis
. 2014;58(1):e1-e34. doi:10.1093/cid/cit665PubMedGoogle ScholarCrossref